Today is September 14, 2024.
All times in Eastern Daylight Time.
-
Ault Alliance Reports Second Quarter 2024 Financial Results, Including Revenue of $76 Million for the Six Months Ended June 30, 2024
LAS VEGAS--(BUSINESS WIRE)--Ault Alliance Reports 2nd Quarter 2024 Financial Results, Including Revenue of $76 Million for 6 Months Ended June 30, 2024; Divest Remaining Assets more »
-
Terran Orbital’s Tyvak Awarded $254 million Prototype Agreement for Tranche 2 Transport Layer (T2TL) Gamma for Space Development Agency
BOCA RATON, Fla.--(BUSINESS WIRE)--Tyvak Nano-Satellite Systems, Inc., Irvine, California (a Terran Orbital Corporation) (NYSE: LLAP) (“Terran Orbital” or the “Company”), a global leader in satelli... more »
-
Metals Acquisition Limited Provides Notice of Release of Half Year Accounts 2024 Results and Conference Call Details
ST. HELIER, Jersey--(BUSINESS WIRE)--Metals Acquisition Limited (NYSE: MTAL; ASX:MAC) Metals Acquisition Limited ARBN 671 963 198 (NYSE: MTAL; ASX: MAC), a private limited company incorporated unde... more »
-
SYM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Symbotic Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Symbotic business and prospects, resulting in its stock trading at inflated prices. more »
-
EXTR INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against Extreme Networks, Inc. and Announces Opportunity for Investors with Substantial Losses to Lead Case
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements re: Extreme Networks business and prospects, resulting in its stock trading at inflated prices. more »
-
PDD INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that PDD Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning PDD business and prospects, resulting in its stock trading at inflated prices. more »
-
Carvana Develops First Auction-IRC ‘Megasite’ in Kansas City
KANSAS CITY, Mo.--(BUSINESS WIRE)--Carvana, an industry pioneer for buying and selling used cars online, today announced the development of its first auction and reconditioning ‘Megasite’ in Kansas... more »
-
INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Ford Motor Company Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - F
SAN DIEGO--(BUSINESS WIRE)--The suit alleges defendants issued false statements concerning Ford business and prospects, resulting in its stock trading at inflated prices. more »
-
Network International Slashes Fraud Rates in MEA with Cloud-Hosted FICO Solution
LONDON & DUBAI, United Arab Emirates--(BUSINESS WIRE)--FICO (NYSE: FICO): Highlights: Network International LLC (NI), headquartered in Dubai, has helped banks in the Middle East and Africa prevent ... more »
-
Logitech G and Aimlabs Introduce The Gauntlet - A $100,000+ Tournament With Cash Prizes and Exclusive Rewards
LAUSANNE, Switzerland & SAN JOSE, Calif.--(BUSINESS WIRE)--Logitech G, a brand of Logitech (SIX: LOGN) (NASDAQ: LOGI) and leader in gaming technologies and gear, announced today that they have part... more »
-
HAFNIA LIMITED: Notice of Scheme Meeting Regarding the Redomiciliation to Singapore
SINGAPORE--(BUSINESS WIRE)--Reference is made to the stock exchange announcement made by Hafnia Limited ("Hafnia” or the "Company", OSE ticker code: “HAFNI”, NYSE ticker code “HAFN”) on 6 August 20... more »
-
ENHERTU® Type II Variation Application Validated by EMA for Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following At Least One Endocrine Therapy
TOKYO & MUNICH--(BUSINESS WIRE)--ENHERTU Type II Variation Application Validated by EMA for HER2 Low or HER2 Ultralow Metastatic Breast Cancer Following At Least One Endocrine Therapy more »
-
ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Certain Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--ENHERTU® Granted Breakthrough Therapy Designation in U.S. for Certain Patients with HER2 Low or HER2 Ultralow Metastatic Breast Cancer more »
-
CXM Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Sprinklr, Inc.
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Sprinklr, Inc. (CXM) Misled Investors Regarding Its Difficulties Scaling the CCaaS Market more »
-
EXTR Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Extreme Networks, Inc.
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Extreme Networks, Inc. (EXTR) Misled Investors Regarding its Business Prospects more »
-
MRNA Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Moderna, Inc.
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Moderna, Inc. (MRNA) Misled Investors Regarding the Efficacy of its RSV Vaccine more »
-
NANO Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Nano Nuclear Energy Inc.
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP is Investigating Allegations that Nano Nuclear Energy Inc. (NNE) Misled Investors Regarding the Timeline for its Commercial Operations more »
-
Applied Materials, Inc. (AMAT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Materials, Inc. (“Applied Materials” or ... more »
-
Calling All Kellanova (K) Investors: Contact Bronstein, Gewirtz & Grossman, LLC Today
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating the merger between Mars, Inc. (“Mars”) and Kellanova (NYSE: K). Investors who purchased Kell... more »
-
ZoomInfo Technologies Inc. (ZI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ZoomInfo Technologies Inc. (“ZoomInfo” or “the C... more »
-
SPIR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Spire Global, Inc. and Encourages Investors to Contact the Firm!
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Spire Global, Inc. (“Spire” or “the Company”) (N... more »
-
Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Globus Medical, Inc. (“Globus Medical” or “the C... more »
-
Ibotta, Inc. (IBTA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ibotta, Inc. (“Ibotta” or “the Company”) (NYSE:... more »
-
Cardlytics, Inc. (CDLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cardlytics, Inc. (“Cardlytics” or “the Company”)... more »
-
Actinium Pharmaceuticals, Inc. (ATNM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Actinium Pharmaceuticals, Inc. (“Actinium” or “t... more »
|
|
